Effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthma

Effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthma

OBJECTIVE. This study evaluated the effects of ebastine on serum eosinophil cationic protein (ECP) levels in patients with bronchial asthma. PATIENTS. Twenty patients with bronchial asthma and low efficiency of current therapy (11 patients with atopic disease and 9 with non-atopic disease) were enro...

Full description

Bibliographic Details
Main Authors:	T. Horiguchi, S. Tachikawa, J. . Kasahara, Y. . Sasaki, M. . Hirose, M. . Shiga, R. Kondo, J. Miyazaki, M. . Sugiyama
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2013-12-01
Series:	Медицинский совет
Subjects:	бронхиальная астма катионный белок эозинофилов эбастин bronchial asthma eosinophil cationic protein ebastine
Online Access:	https://www.med-sovet.pro/jour/article/view/1144

Similar Items

Eosinophilic cationic protein as a non-invasive marker of the nature of inflammatory response in patients with chronic obstructive pulmonary disease
by: M. A. Karnaushkina, et al.
Published: (2020-04-01)

Airway hyperresponsiveness in bronchial asthma: pathogenesis basics
by: I. A. Deyev, et al.
Published: (2002-12-01)

Bronchial asthma. Alone with the doctor
by: O. S. Drobik, et al.
Published: (2014-12-01)

Quality of life in patients having severe bronchial asthma
by: T. V. Smetanenko, et al.
Published: (2005-12-01)

Ebastine in the treatment of patients with allergic rhinitis
by: A. Yu. Ovchinnikov, et al.
Published: (2019-08-01)

Bronchial asthma in children aged 7-14 years depending on its treatment and control
by: I. K. Bogomolova, et al.
Published: (2014-10-01)

Cytokines and nitric oxide in case of bronchial asthma
by: F. I. Petrovsky, et al.
Published: (2002-03-01)

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01)

Epithelial barrier dysfunction in bronchial asthma
by: R. N. Khramova, et al.
Published: (2022-09-01)

Modern Understanding of Severe Bronchial Asthma
by: A. Yu. Kraposhina, et al.
Published: (2022-03-01)

Sputum as a source of adipokines in bronchial asthma
by: V. N. Mineev, et al.
Published: (2014-09-01)

Bronchial Asthma and COVID-19: Comorbidity Issues
by: E. S. Ovsyannikov, et al.
Published: (2021-09-01)

Improved Bioavailability of Ebastine through Development of Transfersomal Oral Films
by: Nayyer Islam, et al.
Published: (2021-08-01)

The role of neurotrophic growth factors in the pathophysiology of bronchial asthma associated with obesity
by: O. Yu. Kytikova, et al.
Published: (2021-04-01)

Risk factors for bronchial asthma in children in Chita Region
by: I. N. Gaimolenko, et al.
Published: (2007-12-01)

Clinical features of bronchial asthma in children with mental disorders
by: E. S. Ryngachenko, et al.
Published: (2022-04-01)

Using the method of laser spectroscopy in the evaluation of the therapy effectiveness in patients with severe bronchial asthma
by: L. A. Krasnobayeva, et al.
Published: (2011-08-01)

Comparative epidemiological characteristics of bronchial asthma according to data of International Study of Asthma and Allergy in Childhood (ISAAC)
by: Ye. M. Kamaltynova, et al.
Published: (2009-08-01)

Quality of life: actual of problem and characteristics quality of life children with bronchial asthma
by: Ye. L. Timoshina, et al.
Published: (2009-08-01)

Epidemiologic investigation of the efficiency of bronchial asthma preventive pharmacotherapy (ETAC)
by: O. S. Fyodorova, et al.
Published: (2004-09-01)

Dynamics of gas evolutions in patients with a heavy bronchial asthma on a background of basic anti-inflammatory therapy
by: L. A. Krasnobayeva, et al.
Published: (2010-12-01)

Clinical features of obesity in children with bronchial asthma
by: I. L. Alimova, et al.
Published: (2017-11-01)

PEDIATRIC BRONCHIAL ASTHMA: MODERN TREATMENT ASPECTS
by: O.V. Zaitseva, et al.
Published: (2011-11-01)

The mechanisms of activization of endothelium at the pregnant patients with bronchial asthma and gestosis
by: A. Sh. Makhmutkhodzhaev, et al.
Published: (2002-06-01)

Mistakes of diagnostics, conducting and treatments of the patients with bronchial asthma
by: N. A. Karoly, et al.
Published: (2002-03-01)

Antileukotrienes in the treatment of bronchial asthma in children: expected and real success
by: Y. L. Mizernitsky
Published: (2014-12-01)

ALLERGIC RHINITIS AS A RISK FACTOR OF THE DEVELOPMENT OF BRONCHIAL ASTHMA IN CHILDREN
by: V.A. Revyakina, et al.
Published: (2006-03-01)

GENE EXPRESSION DYNAMICS IN PATIENTS WITH SEVERE THERAPY-RESISTANT ASTHMA DURING TREATMENT PERIOD
by: Ye. S. Kulikov, et al.
Published: (2014-02-01)

Heart rate variability in bronchial asthma patients
by: I. G. Fomina, et al.
Published: (2007-10-01)

CLINICAL AND IMMUNOLOGICAL FEATURES OF BRONCHIAL ASTHMA ACCOMPANIED BY THYROID GLAND DISORDERS
by: I. A. Kamaeva, et al.
Published: (2014-07-01)

CLINICAL-IMMUNOLOGICAL EFFECTIVENESS OF RIBOMUNYL IN CHILDREN WITH VIRUS-INDUCED BRONCHIAL ASTHMA
by: E. B. Belan, et al.
Published: (2020-12-01)

Features of the course of bronchial asthma in children with a history of bronchopulmonary dysplasia
by: D. Yu. Ovsyannikov, et al.
Published: (2020-09-01)

Optimizing assessment of risk factors for severe bronchial asthma
by: N. L. Potapova, et al.
Published: (2020-03-01)

Efficacy and safety of mometasone furoate/formoterol combination in patients with bronchial asthma
by: A. V. Emelyanov
Published: (2015-12-01)

Using of oxygenic infusion solutions in treatment of patients with bronchial asthma
by: E. V. Belousov, et al.
Published: (2003-03-01)

Evaluation of controller medication efficiency in patients with moderate and severe uncontrolled asthma
by: P. A. Selivanova
Published: (2009-02-01)

Clinical and endoscopic peculiarities of gastroesophageal reflux disease during bronchial asthma combined with chronic opisthorchosis
by: G. M. Chernyavskaya, et al.
Published: (2003-12-01)

Clinical-functional peculiarities in the course of bronchial asthma in combination with the hypertonic disease
by: T. A. Zaripova, et al.
Published: (2009-08-01)

Stability-indicating RP-HPLC method applied to the quantification of anti-histaminic drug ebastine in its oral suspension dosage form
by: Swathi Koduru, et al.
Published: (2023-01-01)

Stability-indicating RP-HPLC method applied to the quantification of anti-histaminic drug ebastine in its oral suspension dosage form
by: Swathi Koduru, et al.
Published: (2023-01-01)